VaramirStart free · no cardSign in
DNTH as of Oct 31 · 17:26 ET
DNTHNasdaqPharmaceutical Preparations

Dianthus Therapeutics, Inc. · Brief

Next report

4 days

Nov 4 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
1 of 8≥ implied
avg implied
±12.9%
avg realized
±5.4%
May 12 '25±26.5%▼−6.18%×0.23
Aug 7 '25±23.0%▼−2.04%×0.09
Oct 16 '25±4.6%▼−0.55%×0.12
Nov 5 '25±10.8%▲+8.00%×0.74
Jan 12 '26±9.0%▲+2.44%×0.27
Q1 FY26±11.9%▲+21.52%×1.80
May 5 '26±7.6%▲+0.20%×0.03
Q2 FY26±9.7%▲+1.90%×0.20
quarterimplied−30%0+30%realized×
Q2 FY26±9.7%▲+1.90%×0.20
May '26±7.6%▲+0.20%×0.03
Q1 FY26±11.9%▲+21.52%×1.80
Jan '26±9.0%▲+2.44%×0.27
Nov '25±10.8%▲+8.00%×0.74
Oct '25±4.6%▼−0.55%×0.12
2 older reports
Aug '25±23.0%▼−2.04%×0.09
May '25±26.5%▼−6.18%×0.23
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 3

269managers reporting a position in the latest quarterly filings13F · Jun 30 '26
3disclosed supplier and customer ties reported in SEC filingsSEC filings

Bear1

1.18%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

DNTH report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±12.6% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.